Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection.
暂无分享,去创建一个
Claudia Pellacani | L. Costa | C. Pellacani | C. Furlong | T. Cole | Clement E Furlong | Rian de Laat | K. Dao | Lucio G Costa | Rian de Laat | Khoi Dao | Toby B Cole
[1] A. Depino. Peripheral and central inflammation in autism spectrum disorders , 2013, Molecular and Cellular Neuroscience.
[2] L. Costa,et al. Modulation of paraoxonase (PON1) activity. , 2005, Biochemical pharmacology.
[3] M. Maraschin,et al. Yerba mate (Ilex paraguariensis) enhances the gene modulation and activity of paraoxonase-2: in vitro and in vivo studies. , 2012, Nutrition.
[4] H. Adami,et al. Epidemiology and etiology of Parkinson’s disease: a review of the evidence , 2011, European Journal of Epidemiology.
[5] M. Martinoli,et al. Protective Effects of Resveratrol and Quercetin Against MPP+ -Induced Oxidative Stress Act by Modulating Markers of Apoptotic Death in Dopaminergic Neurons , 2009, Cellular and Molecular Neurobiology.
[6] T. Hayek,et al. Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglycerides (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: studies in PON2-deficient mice. , 2010, Atherosclerosis.
[7] L. Goya,et al. Quercetin Modulates NF-κ B and AP-1/JNK Pathways to Induce Cell Death in Human Hepatoma Cells , 2010, Nutrition and cancer.
[8] S. Reddy,et al. Adenovirus mediated expression of human paraoxonase 2 protects against the development of atherosclerosis in apolipoprotein E-deficient mice. , 2006, Molecular genetics and metabolism.
[9] A. S. Darvesh,et al. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity , 2010, Neuroscience.
[10] Ying Sun,et al. Female Adult Mouse Cardiomyocytes Are Protected Against Oxidative Stress , 2010, Hypertension.
[11] J. Joven,et al. Human tissue distribution of paraoxonases 1 and 2 mRNA , 2010, IUBMB life.
[12] M. Marino,et al. Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor alpha-dependent mechanisms. , 2009, Molecular nutrition & food research.
[13] T. Kavanagh,et al. Gender differences in brain susceptibility to oxidative stress are mediated by levels of paraoxonase-2 expression. , 2013, Free radical biology & medicine.
[14] S. Scherer,et al. Human PON2 gene at 7q21.3: cloning, multiple mRNA forms, and missense polymorphisms in the coding sequence. , 1998, Gene.
[15] Michael Aviram,et al. Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta. , 2009, Cardiovascular research.
[16] U. Förstermann,et al. Beyond reduction of atherosclerosis: PON2 provides apoptosis resistance and stabilizes tumor cells , 2011, Cell Death and Disease.
[17] R. Haley,et al. Dominant Role of Paraoxonases in Inactivation of the Pseudomonas aeruginosa Quorum-Sensing Signal N-(3-Oxododecanoyl)-l-Homoserine Lactone , 2008, Infection and Immunity.
[18] L. Garcia-Segura,et al. Actions of estrogens on glial cells: Implications for neuroprotection. , 2010, Biochimica et biophysica acta.
[19] M. Aviram,et al. Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages. , 2004, Free radical biology & medicine.
[20] G. Jarvik,et al. Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. , 2003, Annual review of medicine.
[21] Sang Hoon Kim,et al. Transcriptional activation of an anti-oxidant mouse Pon2 gene by dexamethasone. , 2009, BMB reports.
[22] B. La Du,et al. Pharmacogenetics of paraoxonases: a brief review , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[23] Lorene M Nelson,et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. , 2003, American journal of epidemiology.
[24] P. McElduff,et al. The paraoxonase‐2‐310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus , 2005, Journal of internal medicine.
[25] E. Levy,et al. Biological role, protein expression, subcellular localization, and oxidative stress response of paraoxonase 2 in the intestine of humans and rats. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[26] S. Arnold,et al. Estrogen and the regulation of mitochondrial structure and function in the brain , 2012, The Journal of Steroid Biochemistry and Molecular Biology.
[27] B. Ossola,et al. The multiple faces of quercetin in neuroprotection , 2009, Expert opinion on drug safety.
[28] S. Reddy,et al. Impaired hepatic insulin signalling in PON2-deficient mice: a novel role for the PON2/apoE axis on the macrophage inflammatory response. , 2011, The Biochemical journal.
[29] Aldons J Lusis,et al. Paraoxonase-2 Deficiency Aggravates Atherosclerosis in Mice Despite Lower Apolipoprotein-B-containing Lipoproteins , 2006, Journal of Biological Chemistry.
[30] V. A. Villar,et al. Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidase. , 2012, Free radical biology & medicine.
[31] R. Eliakim,et al. Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2. , 2005, Free radical biology & medicine.
[32] B. La Du,et al. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. , 1996, Genomics.
[33] S. Reddy,et al. Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1 Published, JLR Papers in Press, December 16, 2008. , 2009, Journal of Lipid Research.
[34] Jordi Oliver,et al. Age and sex-related changes in rat brain mitochondrial oxidative status , 2011, Experimental Gerontology.
[35] S. Reddy,et al. Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis. , 2009, Antioxidants & redox signaling.
[36] Z. Madar,et al. Glabridin, a phytoestrogen from licorice root, up‐regulates manganese superoxide dismutase, catalase and paraoxonase 2 under glucose stress , 2011, Phytotherapy research : PTR.
[37] Xia Yang,et al. A Common Mutation in Paraoxonase-2 Results in Impaired Lactonase Activity* , 2009, The Journal of Biological Chemistry.
[38] B. Weiss. Same sex, no sex, and unaware sex in neurotoxicology. , 2011, Neurotoxicology.
[39] P. Beart,et al. Oxidative stress: emerging mitochondrial and cellular themes and variations in neuronal injury. , 2010, Journal of Alzheimer's disease : JAD.
[40] A. Tward,et al. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. , 2000, Pharmacogenetics.
[41] D. Shih,et al. Paraoxonase-2 deficiency enhances Pseudomonas aeruginosa quorum sensing in murine tracheal epithelia. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[42] S. Reddy,et al. Paraoxonase-2 Is a Ubiquitously Expressed Protein with Antioxidant Properties and Is Capable of Preventing Cell-mediated Oxidative Modification of Low Density Lipoprotein* , 2001, The Journal of Biological Chemistry.
[43] M. Aviram,et al. Macrophage paraoxonase 2 (PON2) expression is upregulated by unesterified cholesterol through activation of the phosphatidylinositol 3-kinase (PI3K) pathway , 2007, Biological chemistry.
[44] C. Carlson,et al. The Functional Consequences of Polymorphisms in the Human PON1 Gene , 2008 .
[45] Y. Pi,et al. Association between paraoxonase 2 Ser311Cys polymorphism and ischemic stroke risk: a meta-analysis involving 5,008 subjects , 2011, Molecular Biology Reports.
[46] L. Costa,et al. Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role? , 2011, Toxicology and applied pharmacology.
[47] E. Levy,et al. The three-gene paraoxonase family: physiologic roles, actions and regulation. , 2011, Atherosclerosis.
[48] R. Kavlock,et al. Implications of gender differences for human health risk assessment and toxicology. , 2007, Environmental research.
[49] R. Gainetdinov,et al. The Physiology, Signaling, and Pharmacology of Dopamine Receptors , 2011, Pharmacological Reviews.
[50] R. Sunahara,et al. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificitiess⃞s⃞ The online version of this article (available at http://www.jlr.org) contains additional text, figures, and references. Published, JLR Papers in Press, March 16, 2005. DOI 10.1194/jlr.M , 2005, Journal of Lipid Research.
[51] B. Liu,et al. Sex differences in methamphetamine toxicity in mice: Effect on brain dopamine signaling pathways , 2011, Psychoneuroendocrinology.
[52] L. Costa,et al. Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. , 2011, Biochemical pharmacology.
[53] L. Costa,et al. Modulation of Paraoxonase 2 (PON2) in Mouse Brain by the Polyphenol Quercetin: A Mechanism of Neuroprotection? , 2013, Neurochemical Research.
[54] Manabu T. Nakamura,et al. Increased macrophage cholesterol biosynthesis and decreased cellular paraoxonase 2 (PON2) expression in Delta6-desaturase knockout (6-DS KO) mice: beneficial effects of arachidonic acid. , 2010, Atherosclerosis.
[55] C. Watson,et al. Mouse Macrophage Paraoxonase 2 Activity Is Increased Whereas Cellular Paraoxonase 3 Activity Is Decreased Under Oxidative Stress , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[56] T. Hong,et al. Effect of Quercetin in the 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-Induced Mouse Model of Parkinson's Disease , 2012, Evidence-based complementary and alternative medicine : eCAM.
[57] S. Klein,et al. The effects of hormones on sex differences in infection: from genes to behavior , 2000, Neuroscience & Biobehavioral Reviews.
[58] G. Rimbach,et al. Effect of Quercetin on Paraoxonase 2 Levels in RAW264.7 Macrophages and in Human Monocytes––Role of Quercetin Metabolism , 2009, International journal of molecular sciences.
[59] S. Arnold,et al. Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons. , 2010, Biochimica et biophysica acta.
[60] L. Garcia-Segura,et al. Neuroprotective actions of estradiol revisited , 2011, Trends in Endocrinology & Metabolism.
[61] M. Aschner,et al. Gender and manganese exposure interactions on mouse striatal neuron morphology. , 2011, Neurotoxicology.
[62] J. Simpkins,et al. Mitochondrial mechanisms of estrogen neuroprotection. , 2010, Biochimica et biophysica acta.
[63] U. Förstermann,et al. Paraoxonases-2 and -3 Are Important Defense Enzymes against Pseudomonas aeruginosa Virulence Factors due to Their Anti-Oxidative and Anti-Inflammatory Properties , 2012, Journal of lipids.
[64] D. Surmeier,et al. The origins of oxidant stress in Parkinson's disease and therapeutic strategies. , 2011, Antioxidants & redox signaling.
[65] C. Franceschi,et al. Paraoxonase2 C311S polymorphism and low levels of HDL contribute to a higher mortality risk after acute myocardial infarction in elderly patients. , 2009, Molecular genetics and metabolism.
[66] T. Emanuelli,et al. Protective properties of quercetin against DNA damage and oxidative stress induced by methylmercury in rats , 2011, Archives of Toxicology.
[67] S. Reis,et al. Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. , 2003, American journal of human genetics.
[68] R. Haley,et al. Paraoxonase 2 is down-regulated by the Pseudomonas aeruginosa quorumsensing signal N-(3-oxododecanoyl)-L-homoserine lactone and attenuates oxidative stress induced by pyocyanin. , 2010, The Biochemical journal.
[69] U. Förstermann,et al. Paraoxonase-2 Reduces Oxidative Stress in Vascular Cells and Decreases Endoplasmic Reticulum Stress–Induced Caspase Activation , 2007, Circulation.
[70] B. Halliwell. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? , 2008, Archives of biochemistry and biophysics.
[71] E. Levy,et al. Comparative expression analysis reveals differences in the regulation of intestinal paraoxonase family members. , 2009, The international journal of biochemistry & cell biology.
[72] A. Tward,et al. Expression of human paraoxonase (PON1) during development. , 2003, Pharmacogenetics.
[73] Corinna Wu,et al. Of Mice and Women: The Bias in Animal Models , 2010 .
[74] S. Arnold,et al. Sex‐ and brain region‐specific role of cytochrome c oxidase in 1‐methyl‐4‐phenylpyridinium‐mediated astrocyte vulnerability , 2011, Journal of neuroscience research.
[75] T. Hayek,et al. Decreased Macrophage Paraoxonase 2 Expression in Patients With Hypercholesterolemia Is the Result of Their Increased Cellular Cholesterol Content: Effect of Atorvastatin Therapy , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[76] Protective Role of Quercetin on PCBs-Induced Oxidative Stress and Apoptosis in Hippocampus of Adult Rats , 2012, Neurochemical Research.
[77] M. Aviram,et al. Urokinase Plasminogen Activator Upregulates Paraoxonase 2 Expression in Macrophages Via an NADPH Oxidase-Dependent Mechanism , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[78] R. Niranjan. The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson’s Disease: Focus on Astrocytes , 2013, Molecular Neurobiology.
[79] The female advantage in cardiovascular disease: Do vascular beds contribute equally? , 2007 .
[80] Sally Helgesen,et al. The Female Advantage , 1990 .
[81] M. Aviram,et al. Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation. , 2007, Atherosclerosis.
[82] U. Förstermann,et al. One Enzyme, Two Functions , 2010, The Journal of Biological Chemistry.
[83] J. Joven,et al. Immunohistochemical analysis of paraoxonases-1, 2, and 3 expression in normal mouse tissues. , 2008, Free radical biology & medicine.
[84] A. Tamas,et al. Age and gender differences in behavioral and morphological outcome after 6-hydroxydopamine-induced lesion of the substantia nigra in rats , 2005, Behavioural Brain Research.
[85] M. Hayashi. Oxidative stress in developmental brain disorders , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.
[86] C. Disteche,et al. Paraoxonase (PON1) gene in mice: sequencing, chromosomal localization and developmental expression. , 1997, Pharmacogenetics.
[87] Malcolm K Horne,et al. Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. , 2005, Biochemical pharmacology.
[88] Yangbo Guo,et al. Possible association between Cys311Ser polymorphism of paraoxonase 2 gene and late-onset Alzheimer's disease in Chinese. , 2004, Brain research. Molecular brain research.
[89] J. Joven,et al. Pharmacological and lifestyle factors modulating serum paraoxonase-1 activity. , 2009, Mini reviews in medicinal chemistry.